{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:27:18Z","timestamp":1788474438010,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Croatian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.03.033","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T07:28:17Z","timestamp":1458631697000},"page":"2383-2389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants"],"prefix":"10.1016","volume":"34","author":[{"given":"Jelena","family":"Ivancic-Jelecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubravko","family":"Forcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Jagusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Kosutic-Gulija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Mazuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Lang Balija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Isakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Shomron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.033_bib0210","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1099\/0022-1317-69-11-2893","article-title":"Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus","volume":"69","author":"Elango","year":"1988","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0168-1702(89)90054-3","article-title":"Nucleotide sequence of the matrix, fusion and putative SH protein genes of mumps virus and their deduced amino acid sequences","volume":"12","author":"Elliott","year":"1989","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0220","first-page":"3","article-title":"Mumps and mumps vaccine: a global review","volume":"77","author":"Galazka","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0225","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.0954-6820.1943.tb09179.x","article-title":"Involvement of the central nervous system in mumps","volume":"113","author":"Bang","year":"1943","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0230","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00000441-194804000-00012","article-title":"Central nervous system involvement during mumps","volume":"215","author":"Brown","year":"1948","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0235","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/520028","article-title":"Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines","volume":"45","author":"Peltola","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0240","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-1157(89)90031-0","article-title":"Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials","volume":"17","author":"Beck","year":"1989","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0245","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2004.11.013","article-title":"Genetic characterization of L-Zagreb mumps vaccine strain","volume":"109","author":"Ivancic","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0250","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0264-410X(01)00438-8","article-title":"Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain","volume":"20","author":"da Cunha","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0255","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/ije\/31.5.978","article-title":"The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997","volume":"31","author":"da Silveira","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0260","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1016\/j.vaccine.2006.06.025","article-title":"Aseptic meningitis after vaccination with L-Zagreb mumps strain-virologically confirmed cases","volume":"24","author":"Te\u0161ovi\u0107","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0265","series-title":"Global Advisory Committee on Vaccine Safety, 29-30 November 2006. WER","first-page":"18","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0270","doi-asserted-by":"crossref","first-page":"e1001005","DOI":"10.1371\/journal.ppat.1001005","article-title":"Quasispecies theory and the behavior of RNA viruses","volume":"6","author":"Lauring","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0275","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/scientificamerican0793-42","article-title":"Viral quasispecies","volume":"269","author":"Eigen","year":"1993","journal-title":"Sci Am"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0280","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1128\/JVI.00825-08","article-title":"D\u00edaz-San Segundo F, Escarm\u00eds C, Domingo E, Sevilla N. Hidden virulence determinants in a viral quasispecies in vivo","volume":"82","author":"Sanz-Ramos","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0285","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1073\/pnas.88.1.199","article-title":"Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine","volume":"88","author":"Chumakov","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0290","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.1128\/JVI.00355-11","article-title":"Mechanisms controlling virulence thresholds of mixed viral populations","volume":"85","author":"Lancaster","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0295","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature04388","article-title":"Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population","volume":"439","author":"Vignuzzi","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0300","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1126\/science.1115030","article-title":"Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes","volume":"311","author":"Aaskov","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0305","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2006.01.035","article-title":"Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity","volume":"350","author":"Sauder","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0310","doi-asserted-by":"crossref","first-page":"e1005122","DOI":"10.1371\/journal.ppat.1005122","article-title":"Immunostimulatory defective viral genomes from respiratory syncytial virus promote a strong innate antiviral response during infection in mice and humans","volume":"11","author":"Sun","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0315","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.mi.27.100173.000533","article-title":"Defective interfering viruses","volume":"27","author":"Huang","year":"1973","journal-title":"Ann Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0320","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.micinf.2014.11.006","article-title":"Accumulation of defective interfering viral particles in only a few passages in Vero cells attenuates mumps virus neurovirulence","volume":"17","author":"\u0160antak","year":"2015","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0325","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1743-422X-5-79","article-title":"Genetic heterogeneity of L-Zagreb mumps virus vaccine strain","volume":"5","author":"Kosutic-Gulija","year":"2008","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0330","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.meegid.2008.04.007","article-title":"Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains","volume":"8","author":"Ivancic-Jelecki","year":"2008","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0335","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0340","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0345","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/bioinformatics\/btv101","article-title":"Deep sequencing analysis of viral infection and evolution allows rapid and detailed characterization of viral mutant spectrum","volume":"31","author":"Isakov","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0350","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1016\/j.vaccine.2015.06.109","article-title":"In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine","volume":"33","author":"Connaughton","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0355","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biologicals.2012.09.007","article-title":"Vaccine-related mumps infections in Thailand and the identification of a novel mutation in the mumps fusion protein","volume":"41","author":"Gilliland","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0360","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1128\/JVI.72.10.8037-8042.1998","article-title":"Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain","volume":"72","author":"Rubin","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0365","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1128\/JVI.74.11.5382-5384.2000","article-title":"Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans","volume":"74","author":"Rubin","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0370","doi-asserted-by":"crossref","first-page":"11616","DOI":"10.1128\/JVI.77.21.11616-11624.2003","article-title":"Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype","volume":"77","author":"Rubin","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0375","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/428098","article-title":"The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study","volume":"191","author":"Rubin","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0380","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/viro.1994.1353","article-title":"Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine","volume":"202","author":"Rezapkin","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0385","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/viro.1995.1268","article-title":"Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions","volume":"209","author":"Taffs","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0390","doi-asserted-by":"crossref","first-page":"8438","DOI":"10.1128\/JVI.70.12.8438-8443.1996","article-title":"A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with the ability to cause growth hormone deficiency syndrome","volume":"70","author":"Teng","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0395","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm1726","article-title":"Engineering attenuated virus vaccines by controlling replication fidelity","volume":"14","author":"Vignuzzi","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0400","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1128\/JVI.00289-14","article-title":"Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice","volume":"88","author":"Meng","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0405","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/viro.1993.1102","article-title":"Canine distemper virus L gene: sequence and comparison with related viruses","volume":"193","author":"Sidhu","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.03.033_bib0410","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3389\/fmicb.2015.00459","article-title":"The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics","volume":"6","author":"Cox","year":"2015","journal-title":"Front Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16300068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16300068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T15:07:51Z","timestamp":1600355271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16300068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":41,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X16300068"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}